Clinical Trial Update: EndoClot for Preventing Rebleeding After Endoscopic Mucosal Resection (EMR)

View source ↗

Summary

A clinical trial evaluating EndoClot to prevent rebleeding after endoscopic mucosal resection of colonic polyps has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Polyps

Drugs mentioned

• EndoClot

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Endoscopic Hemostasis, Colonic Polyps | Status: COMPLETED